MetaCap

RenovoRx Statistics

NASDAQ: RNXTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.33-0.04 (-2.92%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

RenovoRx by the numbers

RenovoRx has a market capitalization of $60.0 million based on 45.13M shares outstanding. With trailing EPS of $-0.31, RenovoRx is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.2% below its 50-day average and 23.6% above its 200-day average.

Average daily trading volume is 761.09K shares, or about $1.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RNXT valuation vs. peer median

RNXT compared with the median of 8 peer companies
MetricRNXTPeer medianDifference
Market cap$60.02M$59.60M+1%
Avg. volume761.09K427.48K+78%

Peer median across 8 companies: MREO, GOSS, XLO, IBIO, BOLD, PLRX, ALDX, APLM.

Valuation

Market cap
$60.02M
P/E (TTM)
—
Forward P/E
—
EPS (TTM)
$-0.31
Shares outstanding
45.13M

Price and trading

Previous close
1.37
Open
1.33
Day range
1.31 – 1.37
52-week range
0.701 – 2.59
52-week change
+9.92%
50-day moving average
1.52
200-day moving average
1.08
Beta
—
Volume
438.65K
Average volume
761.09K

Dividends and events

Annual dividend
None
Dividend yield
—
Ex-dividend date
—
Next earnings date
Nov 9, 2026

Additional statistics

Market Cap
60.02M
Forward Pe
-11.08
Eps
-0.31
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
2.59
Week52 Low
0.70
Avg Volume
761.09K
Shares Outstanding
45.13M
Ma50
1.52
Ma200
1.08
Earnings Date
Nov 9, 2026
Pct From52w High
-48.65%
Pct From52w Low
89.73%

Related